NDC 0003-0852 – Sprycel
Dasatinib 100 mg/1 · Tablet · Oral
Product NDC0003-0852
Product details
- Brand name
- Sprycel
- Generic name
- dasatinib
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA021986
- Marketed since
- May 30, 2008
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 100 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0003-0852-22 | 1 BOTTLE in 1 CARTON (0003-0852-22) / 30 TABLET in 1 BOTTLE | May 30, 2008 |
Other Sprycel products
- 0003-0524 Dasatinib 70 mg/1 · Tablet · E.R. Squibb & Sons, L.L.C.
- 0003-0527 Dasatinib 20 mg/1 · Tablet · E.R. Squibb & Sons, L.L.C.
- 0003-0528 Dasatinib 50 mg/1 · Tablet · E.R. Squibb & Sons, L.L.C.
- 0003-0855 Dasatinib 80 mg/1 · Tablet · E.R. Squibb & Sons, L.L.C.
- 0003-0857 Dasatinib 140 mg/1 · Tablet · E.R. Squibb & Sons, L.L.C.